Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Pediatr. 2015 Mar 4;166(5):1168–1174.e2. doi: 10.1016/j.jpeds.2015.01.045

Table 4.

Characteristics of Non-Recipients and Daily HTS Recipients Matched by Propensity Score**

Variable Non-Recipients (n=953) Daily HTS (n=953) P-Value
Age (months), mean (SD) 3.82 (3.22) 2.33 (1.76) 0.52
Male Sex, % 59.0 59.4 0.70
Race, %
 Black 13.1 11.1 0.61
 White 71.6 71.7
 Other 13.2 15.6
 Unknown 2.1 1.6
Asthma Diagnosis, % 7.9 6.6 0.53
Insurance Category, %
 Medicaid 68.2 66.5 0.77
 Private Insurance 28.8 29.5
 Self Pay 1.4 2.2
 Other 1.4 1.6
 Unknown 0.3 0.2
Season, %
 Summer (June–Aug) 2.0 1.2 0.66
 Fall (Sept–Nov) 6.8 6.7
 Winter (Dec–Feb) 63.9 62.8
 Spring (Mar–May) 27.3 29.4
Year, %
 2008 0.3 0.4 0.20
 2009 2.9 3.7
 2010 32.2 26.9
 2011 64.5 69.0
Severity, %
 Intensive Care Unit Admission 4.5 3.3 0.37
 Non-Invasive Positive Pressure Ventilation 0.1 0.2 0.41
 Mechanical Ventilation 0.1 0.0 *
 Blood Gas 17.6 14.9 0.12
 Supplemental Oxygen 49.7 51.6 0.66
 APR-DRG severity subclass (major/extreme) 9.4 6.5 0.11
Management, %
 Racemic Epinephrine 42.7 42.5 0.99
 Albuterol 55.0 50.8 0.39
 Corticosteroids 17.9 15.7 0.12
 Continuous Nebulized Therapies 17.1 15.0 0.65
 Intravenous Fluids 51.2 52.2 0.85
 Intravenous Antibiotics 18.4 17.4 0.64
 Chest Radiograph 46.4 45.3 0.52
Hospital, %
 Hospital A 7.4 7.4 0.58
 Hospital B 45.7 47.1
 Hospital C 22.7 23.7
 Hospital D 10.5 10.5
 Hospital E 13.9 11.3
*

P-value not calculated due to empty cells

**

Limited to visits at hospitals with >5% overall HTS use